Scientific Programme
Thursday, 19th June 2008
09:00 – 09:45 Opening ceremony
H. Schatz (
09:45 – 10:15 Guest Lecture: Oxidative stress in diabetes
A. Ceriello (
10:15 – 10:45 Coffee break
10:45 – 12:30 1st Session: Epidemiology, Genetics, Pathogenesis
Obesity and type 2 diabetes
D. Micic (
Genetics of obesity and type-2-diabetes (FTO-, TCF7L2- and other genes)
B. Todorova, J. Salonnen (Sofia; Kuopio)
Nutrition and diabetes development
U. Julius (
Coagulation disturbances in diabetes
D. Tschöpe (Bad Oeynhausen)
12:30 – 13:30 Poster session
13:30 – 14:30 Lunch break
14:30 – 16:15 2nd Session: Prevention, Cardiodiabetes
Physical activity in the prevention of cardiodiabetes
T. Temelkova-Kurktschiev (
Diabetes as a cardiovascular disease
M. Fuchtenbusch (
State of the art lecture: Prevention of cardiovascular disease in type 2
diabetes: How relevant is glucose lowering?
G. Schernthaner (
16:15 – 16:45 Coffee break
16:45 – 18:20 3rd Session: Diabetic Complications and Associated Diseases
Hypertension and type 2 diabetes – which treatment?
J. Sieradzki (
Challenges in the treatment of the elderly diabetic patients
D.
Koev (
Depression in the metabolic syndrome/ type 2 diabetes: mechanisms
and treatment
S. Bornstein (
Diabetic foot
V. Urbancic-Rovan (
18:45 – 19:45 General assembly of FID-members
20:30 “Get Together” Party
Friday, 20. June 2008
09:00-10:30 4th
Session: Diabetic Polyneuropathy – sponsored by Wörwag Pharma
Diabetic polyneuropathy
P. Kempler (
The place of alpha-lipoic acid in the treatment of diabetic neuropathy.
I. A. Veresiu (Cluj-Napoca/Klausenburg)
Treatment of diabetic neuropathy viewed through the prism of Bulgarian
experience.
T. Tankova
(
Benfotiamine in the treatment of diabetic complications and beyond.
A. Stirban (Bad Oeynhausen)
10:30 - 11:00 Coffee break
11:00 – 13:30 5th Session: Therapy of Type 2 Diabetes
Classical antidiabetic drugs – sulfonylureas and metformin in the
treatment of type 2 diabetes
V. Pirags (
Treatment of postprandial hyperglycaemia: acarbose, glinides
O. Schnell (
Glitazones in the treatment of type 2 diabetes according to recent studies and metaanalyses
E. Standl (
New oral antidiabetic drugs: GLP-1 analogues and DPP-IV inhibitors
H. Schatz (
Therapy of diabetic dyslipidemia
C. Saely, H. Drexel (Feldkirch)
Blocking fatty acids' mystery tour: a therapy for metabolic syndrome?
M. Roden (
13:30-14:30 Lunch break
14:30-15:30 Poster session
14:30-15:15 Meet the Professor Session
Oral treatment of type 2 diabetes
M. Hanefeld (
15:30-17:00 6th Session: Insulin Therapy, Type 1 Diabetes
Insulin therapy in type 2 diabetes
R. Weitgasser (Salzburg)
Insulin analogues and pump therapy in children and adolescents
O. Kordonouri (
New data on pancreas and islet cell transplantation in diabetes
R. Lehmann (
17:00 – 17:30 Coffee break
17:30 – 18:45 7th Session: Special Forms of Diabetes
Gestational diabetes: Recommendations for screening and treatment
P. Bottermann (
What should general practitioners know about LADA?
E. Hatziagelaki (
Guidelines for diagnostics and treatment of MODY
J. Stanik (
18:45 Closing ceremony
Invitation to the 4th Central European Diabetes Congress
in Salzburg 2009
R. Weitgasser (Salzburg)
20:00 Gala dinner